Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lifeline-NET (Narrative Exposure Therapy): A Short-term Treatment for Traumatized Refugees and Asylum Seekers

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Martina Ruf, University of Konstanz
ClinicalTrials.gov Identifier:
NCT01720732
First received: August 7, 2012
Last updated: December 1, 2014
Last verified: December 2014
  Purpose
Evaluation of a short version of Narrative Exposure Therapy

Condition Intervention
Trauma Treatment
Lifeline NET
Modification of Narrative Exposure Therapy
Behavioral: Lifeline NET

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment

Further study details as provided by University of Konstanz:

Primary Outcome Measures:
  • PTSD [ Time Frame: 9 months follow up ] [ Designated as safety issue: No ]
    Posttraumatic Stress Disorder Clinician Administered PTSD Scale


Secondary Outcome Measures:
  • Other Symptoms following and related to Trauma, e.g. Depression, Dissociation [ Time Frame: 9 months follow up ] [ Designated as safety issue: No ]
    Other Symptoms following and related to Trauma, e.g. Depression, Dissociation


Other Outcome Measures:
  • Social functioning, Life Satisfaction, Aggression [ Time Frame: 9 months follow up ] [ Designated as safety issue: No ]

Enrollment: 32
Study Start Date: October 2012
Study Completion Date: December 2014
Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Lifeline NET
Lifeline-NET (Short Version of NET)
Behavioral: Lifeline NET
Short Version of Narrative Exposure Therapy
Other Name: LL-NET
No Intervention: TAU
Treatment as Usual

  Eligibility

Ages Eligible for Study:   12 Years to 60 Years   (Child, Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • PTSD

Exclusion Criteria:

  • Psychotic Disorder,
  • Severe Substance Dependence
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01720732

Locations
Germany
University of Konstanz
Konstanz, Germany
Sponsors and Collaborators
University of Konstanz
  More Information

Additional Information:
NGO  This link exits the ClinicalTrials.gov site

Publications:
Schauer M, Neuner F, Elbert T (2005/2011): Narrative Exposure Therapy. A Short-Term Intervention for Traumatic Stress Disorders. 2nd Ed. Cambridge/ Göttingen: Hogrefe & Huber Publishers.

Responsible Party: Martina Ruf, PhD, University of Konstanz
ClinicalTrials.gov Identifier: NCT01720732     History of Changes
Other Study ID Numbers: LL-NET2012 
Study First Received: August 7, 2012
Last Updated: December 1, 2014
Health Authority: University of Konstanz: Germany

ClinicalTrials.gov processed this record on September 23, 2016